PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Puer Research, LLC
Study ID
NCT05687578
Status
Enrolling By Invitation

Conditions

  • Aging

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Accepted

Interventions

  • Measurements Only — DIAGNOSTIC_TEST
    This is an observational study only using biospecimen and imaging-based measurements only

Study Details

This is a minimal risk, prospective, non-randomized, multi-center population based observational study to establish a physical baseline profile for individual study subjects using various modalities (blood draws, non-invasive imaging, stool samples, saliva samples) and identify deviations through longitudinal monitoring that may develop over time and may be relevant to human health and healthy longevity.

Key Dates

Start date
Mar 27, 2023
Status verified
Oct 2024
Primary completion
Jan 31, 2029
Completion
Jan 31, 2030

Study Design

Enrollment
10,000 participants (estimated)

Primary Outcome Measure

Biomarkers that exhibit significant change [ Time Frame: 12 Months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Puer Research, LLCAtlantaGeorgia30350-

Find similar trials in Atlanta, GA

By research site
Puer Research, LLC· Atlanta, GA

Related Studies